Vertex Pharmaceuticals Inc (VRTX) — Technical state

As of 2026-10-09 — re-computed nightly across the coverage universe. Closelooknet diary readings, not advice.

Stochastic turned up

Its stochastic crossed up out of oversold (%K 30.2 over %D 25.1) 3 sessions ago — a short-term momentum-turn signal.

The moving-average stack

vs 20-day-0.7%
vs 50-day-2%
vs 200-day+7.4%
52-week band9% off the high · +36.3% off the low
Streak1 consecutive up session
Stochastic%K 30.2 · %D 25.1 · up cross

Continue: the VRTX chart & overview · quality & forensics · the earnings record · the signal board

FAQ · from the current data · as of 2026-10-09

Quick answers

What is the current Closelooknet signal on VRTX?

Stochastic turned up — Its stochastic crossed up out of oversold (%K 30.2 over %D 25.1) 3 sessions ago — a short-term momentum-turn signal. As of 2026-10-09; the signal board re-computes across the coverage universe nightly. A research diary reading, not advice.

Is VRTX above its 50-day and 200-day moving averages?

As of 2026-10-09, Vertex Pharmaceuticals Inc trades -2% below its 50-day and +7.4% above its 200-day average, with the 20-day -0.7% away.

How far is VRTX from its 52-week high?

9% below the 52-week high and 36.3% above the 52-week low, as of 2026-10-09.

Mentioned on Closelooknet

Where VRTX appears in the diary — 1 piece, newest first. Every link is our own writing.

Dailies

A chart pick published at 95.10 this morning trades 107.92 by midday — Robinhood's triangle breaks up through the 100 shelf — as the CAC snaps seven straight red sessions and Bitcoin adds another six percent above 77,000Midday 10 · 21 Aug 2026Barchart's large-cap 52-week new-high list, as of 11:59 CDT, carries 31 names and reads like the ex-tech thesis printed as breadth: twelve are health care, biotech or pharma — ARGX, BDX, BIO, CORT, HALO, MRK, REGN, RVTY, THC, TVTX, TXG…

Related in the Closelooknet universe

same Closelooknet index seat first, then Biotechnology. Scored names rank on their Closelooknet score; names without one rank on trend state — above or below their 50- and 200-day averages — never on a score they do not carry.